\[^18^F\]FDG-PET/CT performed in three patients with lung cancer demonstrate: A.Axial CT(1), PET(2) and fused PET/CT(3) showed an incidental 46-mm ground-glass opacity (with non-uniform density and air bronchogram), in the superior segment of the right lower lobe with mild diffuse metabolic uptake (SUVmax: 3,9) \[[@bib0005]\],consistent with probable early phase lung infection of the COVID-19 disease \[[@bib0010]\]. B. Axial CT(1), PET(2) and fused PET/CT(3) demonstrated a paramedial consolidation and thickened interlobular septa in the lower right lobe \[[@bib0005],[@bib0015]\] with high focal \[18F\]FDG avidity (SUVmax:5,3) suggesting severe infectious process. C. Axial CT(1), PET(2) and fused PET/CT(3) identified bibasal opacities with decreased density and fibrotic stripes \[[@bib0015]\] which associate an heterogeneous high metabolic uptake (SUVmax:5) \[[@bib0010],[@bib0020]\], consistent with COVID-19 in resolution.

The finding of three different metabolic uptake patterns, highlights the utility of \[18F\]FDG-PET-CT not only to diagnose incidental cases of COVID-19 disease, so security measures can be adopted, but also to distinguish the evolutive situation of it.
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